Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (601-610 of 1,289) with videos related to

Pageof 129
Sort By:
Leukemia|June 9, 1999
Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapyE H Estey, P F Thall, P Reed, et al.
Cancer Investigation|December 11, 1999
Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.
Archives of Environmental Contamination and Toxicology|October 13, 2001
Trace elements in king eiders and common eiders in the Canadian arcticM Wayland, H G Gilchrist, D L Dickson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 19, 2019
Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancerMatthew J Keating, Lisa Giscombe, Toufic Tannous, et al.
JAMA|November 19, 1982
Improved prospects for long-term survival in adults with acute myelogenous leukemiaM J Keating, K B McCredie, G P Bodey, et al.
Blood|January 3, 2001
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcomeL Fayad, M J Keating, J M Reuben, et al.
Blood|March 1, 1984
Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemiaF M Davis, W N Hittelman, K B McCredie, et al.
Leukemia & Lymphoma|March 1, 1995
Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosisC E Bueso-Ramos, T Manshouri, M A Haidar, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Pageof 129

Showing results (601-610 of 1,289) with videos related to

Sort By:
Pageof 129
Leukemia|June 9, 1999
Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapyE H Estey, P F Thall, P Reed, et al.
Cancer Investigation|December 11, 1999
Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.
Archives of Environmental Contamination and Toxicology|October 13, 2001
Trace elements in king eiders and common eiders in the Canadian arcticM Wayland, H G Gilchrist, D L Dickson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 19, 2019
Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancerMatthew J Keating, Lisa Giscombe, Toufic Tannous, et al.
JAMA|November 19, 1982
Improved prospects for long-term survival in adults with acute myelogenous leukemiaM J Keating, K B McCredie, G P Bodey, et al.
Blood|January 3, 2001
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcomeL Fayad, M J Keating, J M Reuben, et al.
Blood|March 1, 1984
Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemiaF M Davis, W N Hittelman, K B McCredie, et al.
Leukemia & Lymphoma|March 1, 1995
Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosisC E Bueso-Ramos, T Manshouri, M A Haidar, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Pageof 129